William C. Hahn

Closest collaborators

The 25 strongest of 68 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Andrew J. Aguirre · 9 shared papers, 1 shared grant, 2018–2026 · strength 1.89
   • Grant Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity U01CA274276↗
   • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
2. Stephanie K. Dougan · 1 shared grant, 2026 · strength 1.00
   • Grant Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity U01CA274276↗
3. Brian Matthew Wolpin · 6 shared papers, 2018–2023 · strength 0.52
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
   • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
   • Paper Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. DOI 10.1016/j.cell.2021.11.017↗
4. Douglas Adam Rubinson · 5 shared papers, 2018–2023 · strength 0.45
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
   • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
   • Paper Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. DOI 10.1016/j.cell.2021.11.017↗
5. Srivatsan Raghavan · 4 shared papers, 2018–2023 · strength 0.41
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
   • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
   • Paper Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. DOI 10.1016/j.cell.2021.11.017↗
6. James M. Cleary · 3 shared papers, 2021–2023 · strength 0.33
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
   • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
   • Paper Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. DOI 10.1016/j.cell.2021.11.017↗
7. Thomas E. Clancy · 4 shared papers, 2018–2023 · strength 0.31
   • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
   • Paper Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. DOI 10.1016/j.cell.2021.11.017↗
   • Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
8. Jonathan Andrew Nowak · 4 shared papers, 2018–2023 · strength 0.31
   • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
   • Paper Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. DOI 10.1016/j.cell.2021.11.017↗
   • Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
9. Charles S. Fuchs · 4 shared papers, 2018–2019 · strength 0.28
   • Paper Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxe… DOI 10.1007/s10637-018-0650-5↗
   • Paper iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer. DOI 10.1158/1535-7163.mct-17-1090↗
   • Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
10. Bjoern Papke · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
11. A. Cole Edwards · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
12. J. Nathaniel Diehl · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
13. Devon R. Blake · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
14. Priya S. Hibshman · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
15. Adrienne D. Cox · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
16. Lee M. Graves · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
17. Jennifer E. Klomp · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
18. Clint A. Stalnecker · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
19. Andrew M. Waters · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
20. Channing J. Der · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
21. G. Aaron Hobbs · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
22. Craig M. Goodwin · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
23. Tikvah K. Hayes · 2 shared papers, 2021–2026 · strength 0.28
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2026.117627↗
    • Paper Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition. DOI 10.1016/j.celrep.2021.109291↗
24. Kimberly J. Perez · 3 shared papers, 2019–2023 · strength 0.26
    • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
    • Paper Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. DOI 10.1016/j.cell.2021.11.017↗
    • Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
25. David C. Linehan · 3 shared papers, 2018–2023 · strength 0.23
    • Paper Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and … DOI 10.1158/0008-5472.can-22-3050↗
    • Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
    • Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.